A Pan-Cyclophilin Inhibitor, CRV431, Decreases Fibrosis and Tumor Development in Chronic Liver Disease ModelsJoseph Kuo(Scripps Research Institute), Daren Ure(NAEJA-RGM Pharmaceuticals (Canada))Journal of Pharmacology and Experimental TherapeuticsAugust 12, 201910.1124/jpet.119.261099Cited by 52SaveCiteExport RISWatch citationsRelated PapersCyclophilin Inhibitor Rencofilstat Combined with Proteasome Inhibitor Ixazomib Increases Proteotoxic Cell Death in Advanced Prostate Cancer Cells with Minimal Effects on Non-Cancer Cells|Biomedicines|2025|0